Skip to main content

Adaptive Biotechnologies: Q1 Earnings Snapshot

SEATTLE (AP) — SEATTLE (AP) — Adaptive Biotechnologies Corp. (ADPT) on Tuesday reported a loss of $20 million in its first quarter.

The Seattle-based company said it had a loss of 13 cents per share.

The results beat Wall Street expectations. The average estimate of four analysts surveyed by Zacks Investment Research was for a loss of 16 cents per share.

The life-sciences research company posted revenue of $70.9 million in the period, also exceeding Street forecasts. Five analysts surveyed by Zacks expected $61.8 million.

Adaptive Biotechnologies shares have dropped 15% since the beginning of the year. In the final minutes of trading on Tuesday, shares hit $13.80, a rise of 38% in the last 12 months.

_____

This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on ADPT at https://www.zacks.com/ap/ADPT

One Tech Tip: What to know about flying with lithium ion portable battery chargers

Jetting off soon for summer travels? If you're planning on bringing an extra battery charger for your phone or other devices, be aware of the latest rules when taking one on a flight. Rechargeable lithium-ion portable battery chargers, also known as power banks, come in protective enclosures of various shapes and sizes. They're a handy and popular way for getting more juice when you're on the move. But after a spate of smoke or fire incidents, U.S. and international aviation authorities have issued new guidelines and airlines have tightened up rules for passengers. Here's a guide on flying with power banks.
Read Next Story